Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Pharmeasy
Pharmeasy is a company founded in 2015 by Mikhil Innani, Dharmil Sheth and Dhaval Shah.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Company
Organization
AngelList URL
angel.co/pharmeasy
Apple App Store URL
apps.apple.com/in/app/...82432643
B2X
B2C
B2B
CEO
Dharmil Sheth
Company Operating Status
Active
Country
India
Crunchbase URL
crunchbase.com/organiz...arm-easy
Email Address
care@pharmeasy.in
Facebook URL
@pharmeasy
Founded Date
January 1, 2015
Founder
Dharmil Sheth
Mikhil Innani
Dhaval Shah
Google Play Store URL
play.google.com/store/a.../details
Industry
Pharmaceutical industry
Medicine
E-commerce
Microbiome and Gut Health
Location-based service
Healthcare
Hyperlocal
Mobile commerce
Android
Instagram URL
instagram.com/pharmeasyapp/
Invested in
F-Prime Capital Partners
Investors
Astarc Ventures
0
Manipal Group
Kotak Realty Fund
Prosus Ventures
IIFL
Trifecta Capital Advisors
InnoVen Capital
0
Caisse de Depot et Placement du Quebec
LGT Group
Temasek Holdings
•••
Latest Funding Round Date
April 7, 2021
Latest Funding Round Amount (USD)
350,000,000
Latest Funding Type
Series E round
LinkedIn URL
@company/pharmeasy
Location
India
Mumbai
Number of Employees (Ranges)
201 – 500
Phone Number
+919992999929
Pitchbook URL
pitchbook.com/profiles...134157-25
Total Funding Amount (USD)
637,000,000
Twitter URL
@pharmeasyapp
Official Website
pharmeasy.in
Wellfound ID
pharmeasy
YouTube Channel
youtube.com/channel/U...H3-KGu8JhA
Find more companies like Pharmeasy
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE